GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » China Isotope & Radiation Corp (HKSE:01763) » Definitions » EV-to-Revenue

China Isotope & Radiation (HKSE:01763) EV-to-Revenue : 0.31 (As of May. 12, 2024)


View and export this data going back to 2018. Start your Free Trial

What is China Isotope & Radiation EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, China Isotope & Radiation's enterprise value is HK$2,245 Mil. China Isotope & Radiation's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$7,257 Mil. Therefore, China Isotope & Radiation's EV-to-Revenue for today is 0.31.

The historical rank and industry rank for China Isotope & Radiation's EV-to-Revenue or its related term are showing as below:

HKSE:01763' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.58   Med: 1   Max: 2.15
Current: 0.31

During the past 9 years, the highest EV-to-Revenue of China Isotope & Radiation was 2.15. The lowest was 0.58. And the median was 1.00.

HKSE:01763's EV-to-Revenue is ranked better than
93.95% of 826 companies
in the Medical Devices & Instruments industry
Industry Median: 3.265 vs HKSE:01763: 0.31

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-12), China Isotope & Radiation's stock price is HK$11.00. China Isotope & Radiation's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$22.69. Therefore, China Isotope & Radiation's PS Ratio for today is 0.48.


China Isotope & Radiation EV-to-Revenue Historical Data

The historical data trend for China Isotope & Radiation's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Isotope & Radiation EV-to-Revenue Chart

China Isotope & Radiation Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only 1.36 1.63 1.11 0.64 0.78

China Isotope & Radiation Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.11 - 0.64 - 0.78

Competitive Comparison of China Isotope & Radiation's EV-to-Revenue

For the Medical Devices subindustry, China Isotope & Radiation's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Isotope & Radiation's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, China Isotope & Radiation's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where China Isotope & Radiation's EV-to-Revenue falls into.



China Isotope & Radiation EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

China Isotope & Radiation's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=2244.802/7257.219
=0.31

China Isotope & Radiation's current Enterprise Value is HK$2,245 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. China Isotope & Radiation's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was HK$7,257 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China Isotope & Radiation  (HKSE:01763) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

China Isotope & Radiation's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=11.00/22.688
=0.48

China Isotope & Radiation's share price for today is HK$11.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was HK$22.69.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China Isotope & Radiation EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of China Isotope & Radiation's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


China Isotope & Radiation (HKSE:01763) Business Description

Traded in Other Exchanges
N/A
Address
No. 66 Changwa Middle Street, Haidian District, Beijing, CHN, 100089
China Isotope & Radiation Corp is a Chinese company. It has five operating segments: Pharmaceuticals; Radioactive source products; Irradiation; Radiation therapy equipment and related services and Other businesses. Its Pharmaceutical segment is the key revenue driver, which manufactures and sells imaging diagnostic and therapeutic radiopharmaceuticals imaging, UBT diagnostic kits, and test analyzers, and other products. Its radioactive source products segment involves the sale of medical and industrial radioactive source products and technical services. The Group's operations are carried out and majority of the Group's customers are located in the PRC.

China Isotope & Radiation (HKSE:01763) Headlines

No Headlines